CVS raises annual profit forecast on improved drug revenues

CVS Health increased its annual profit guidance following better-than-expected second-quarter results driven by an improved pharmaceutical mix and bonus payments from highly-rated government health insurance plans. The company adjusted its 2026 adjusted profit per share forecast to a range of $7.90 to $8.10, up from prior guidance of $7.30 to $7.50. Wall Street analysts had been expecting full-year earnings per share of $7.45.
The pharmacy and insurance operator posted adjusted second-quarter p